Gene · 3276
Papers2,987
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
221 to 240 of 2,987
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| A novel AML1-ETO/FTO positive feedback loop promotes leukemogenesis and Ara-C resistance via stabilizing IGFBP2 in t(8;21) acute myeloid leukemia. | Exp Hematol Oncol | 2024 | 38268050 | PubTator, text mining | PubMed |
| Investigating Protein Binding with the Isothermal Ligand-induced Resolubilization Assay. | Chembiochem | 2024 | 38266114 | PubTator, text mining | PubMed |
| The Role of Protein Methyltransferases in Immunity. | Molecules | 2024 | 38257273 | PubTator, text mining | PubMed |
| Regulation of EZH2 protein stability: new mechanisms, roles in tumorigenesis, and roads to the clinic. | EBioMedicine | 2024 | 38244292 | PubTator, text mining | PubMed |
| The roles and molecular mechanisms of non-coding RNA in cancer metabolic reprogramming. | Cancer Cell Int | 2024 | 38238756 | PubTator, text mining | PubMed |
| LncRNA PSMB8-AS1 increases glioma malignancy via the miR-382-3p/BCAT1 axis. | Transl Oncol | 2024 | 38235619 | PubTator, text mining | PubMed |
| Multipronged regulation of autophagy and apoptosis: emerging role of TRIM proteins. | Cell Mol Biol Lett | 2024 | 38225560 | PubTator, text mining | PubMed |
| Emerging roles of exosomes in oral diseases progression. | Int J Oral Sci | 2024 | 38221571 | PubTator, text mining | PubMed |
| PRMT1 Integrates Immune Microenvironment and Fatty Acid Metabolism Response in Progression of Hepatocellular Carcinoma. | J Hepatocell Carcinoma | 2024 | 38213310 | PubTator, text mining | PubMed |
| Hematopoietic stem cell quiescence and DNA replication dynamics maintained by the resilient β-catenin/Hoxa9/Prmt1 axis. | Blood | 2024 | 38211335 | PubTator, text mining | PubMed |
| Current and future therapeutic strategies for high-grade gliomas leveraging the interplay between epigenetic regulators and kinase signaling networks. | J Exp Clin Cancer Res | 2024 | 38183103 | PubTator, text mining | PubMed |
| Advances in invasive micropapillary carcinoma of the breast research: A review. | Medicine (Baltimore) | 2024 | 38181281 | PubTator, text mining | PubMed |
| The long noncoding RNA HNF1A-AS1 with dual functions in the regulation of cytochrome P450 3A4. | Biochem Pharmacol | 2024 | 38176619 | PubTator, text mining | PubMed |
| The disruptor of telomeric silencing 1-like (DOT1L) promotes peritoneal fibrosis through the upregulation and activation of protein tyrosine kinases. | Mol Biomed | 2024 | 38172378 | PubTator, text mining | PubMed |
| Heterogeneous nuclear ribonucleoprotein K promotes cap-independent translation initiation of retroviral mRNAs. | Nucleic Acids Res | 2024 | 38165048 | PubTator, text mining | PubMed |
| The BCL-2 inhibitor APG-2575 resets tumor-associated macrophages toward the M1 phenotype, promoting a favorable response to anti-PD-1 therapy via NLRP3 activation. | Cell Mol Immunol | 2024 | 38062129 | PubTator, text mining | PubMed |
| Gambogic acid inhibits HBx-mediated hepatitis B virus replication by targeting the DTX1-Notch signaling pathway. | Virus Res | 2024 | 38029800 | PubTator, text mining | PubMed |
| Histone H4 asymmetrically dimethylated at arginine 3 (H4R3me2a), a mark of super-enhancers. | Biochem Cell Biol | 2024 | 38011682 | PubTator, text mining | PubMed |
| RPF2 mediates the CARM1‑MYCN axis to promote chemotherapy resistance in colorectal cancer cells. | Oncol Rep | 2024 | 37997821 | PubTator, text mining | PubMed |
| PRMT1 Inhibition Activates the Interferon Pathway to Potentiate Antitumor Immunity and Enhance Checkpoint Blockade Efficacy in Melanoma. | Cancer Res | 2024 | 37991725 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3276/papers?page=12